The MDx Impact Grants support research groups worldwide to develop PCR-based diagnostic tests addressing unmet clinical needs in neurodegenerative diseases, focusing on Alzheimer's disease. Funded projects utilize Seegene's high-multiplex PCR platform for detecting molecular markers and assessing disease staging and progression through clinical studies, with grants up to $600,000.
Eligible research groups worldwide may apply. Each group can submit only one application focused on the designated project.
